ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
29 1월 2024 - 8:50PM
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today
announced that Nikhil Lalwani, Chief Executive Officer, will
participate in a fireside chat at the Guggenheim Healthcare Talks |
6th Annual Biotechnology Conference in New York City as follows:
Date: |
|
Thursday,
February 8, 2024 |
|
|
|
Time: |
|
10:30 a.m. ET |
|
|
|
Webcast: |
|
Click Here |
|
|
|
To schedule a 1x1 meeting with the Company, please email:
gsmanagementaccess@guggenheimpartners.com
The live and archived webcast will be accessible from the
Company’s website at www.anipharmaceuticals.com, under the
Investors section under Events and Presentations. The replay of the
webcast will be accessible for 30 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. Our team is focused on delivering
sustainable growth by scaling up our Rare Disease business through
the successful launch of our lead asset, Purified Cortrophin® Gel,
strengthening our generics business with enhanced research and
development capability, innovation in established brands and
leveraging our North American manufacturing capabilities. For more
information, please visit our website
www.anipharmaceuticals.com.
Investor Relations: Lisa M. Wilson,
In-Site Communications, Inc.T:
212-452-2793 E:
lwilson@insitecony.comSource: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024